|
1
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010.
|
|
2
|
Kroeze SG, Bijenhof AM, Bosch JL and Jans
JJ: Diagnostic and prognostic tissuemarkers in clear cell and
papillary renal cell carcinoma. Cancer Biomark. 7:261–268.
2010.PubMed/NCBI
|
|
3
|
Pischon T, Lahmann PH, Boeing H, et al:
Body size and risk of renal cell carcinoma in the European
prospective investigation into cancer and nutrition (EPIC). Int J
Cancer. 118:728–738. 2006. View Article : Google Scholar
|
|
4
|
Eichelberg C, Junker K, Ljungberg B and
Moch H: Diagnostic and prognostic molecular markers for renal cell
carcinoma: a critical appraisal of the current state of research
and clinical applicability. Eur Urol. 55:851–863. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wulfken LM, Moritz R, Ohlmann C, et al:
MicroRNAs in renal cell carcinoma: diagnostic implications of serum
miR-1233 levels. PLoS One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sana J, Faltejskova P, Svoboda M and Slaby
O: Novel classes of non-coding RNAs and cancer. J Transl Med.
10:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro- RNA genes miR15
and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao X, Zhang R, Qu X, et al: MiR-15a,
miR-16-1 and miR-17-92 cluster expression are linked to poor
prognosis in multiple myeloma. Leuk Res. 36:1505–1509. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bottoni A, Piccin D, Tagliati F, et al:
miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell
Physiol. 204:280–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teshima K, Nara M, Watanabe A, et al:
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an
anti-apoptotic potential in the side population of refractory
mantle cell lymphoma. Oncogene. 33:2191–2203. 2014. View Article : Google Scholar
|
|
12
|
Bandi N, Zbinden S, Gugger M, et al:
miR-15a and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Porkka KP, Ogg EL, Saramäki OR, et al: The
miR-15a-miR-16-1 locus is homozygously deleted in a subset of
prostate cancers. Genes Chromosomes Cancer. 50:499–509. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
16
|
Jung M, Mollenkopf HJ, Grimm C, et al:
MicroRNA profiling of clear cell renal cell cancer identifies a
robust signature to define renal malignancy. J Cell Mol Med.
13:3918–3928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kosari F, Parker AS, Kube DM, et al: Clear
cell renal cell carcinoma: gene expression analyses identify a
potential signature for tumor aggressiveness. Clin Cancer Res.
11:5128–5139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
20
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo CJ, Pan Q, Li DG, Sun H and Liu BW:
miR-15b and miR-16 are implicated in activation of the rat hepatic
stellate cell: An essential role for apoptosis. J Hepatol.
50:766–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bonci D, Coppola V, Musumeci M, et al: The
miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med. 14:1271–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brugarolas J: PBRM1 and BAP1 as novel
targets for renal cell carcinoma. Cancer J. 19:324–332. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gossage L, Murtaza M, Slatter AF, et al:
Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A
and JARID1c in clear cell renal cell carcinoma. Genes Chromosomes
Cancer. 53:38–51. 2014. View Article : Google Scholar
|
|
25
|
Kapur P, Christie A, Raman JD, et al: BAP1
immunohistochemistry predicts outcomes in a multi-institutional
cohort with clear cell renal cell carcinoma. J Urol. 191:603–610.
2014. View Article : Google Scholar
|
|
26
|
Kalinowski FC, Brown RA, Ganda C, et al:
microRNA-7: A tumor suppressor miRNA with therapeutic potential.
Int J Biochem Cell Biol. 54:312–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu Z, Ni L, Chen D, et al: Identification
of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol.
44:669–677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaefer A, Jung M, Kristiansen G, et al:
MicroRNAs and cancer: Current state and future perspectives in
urologic oncology. Urol Oncol. 28:4–13. 2010. View Article : Google Scholar
|
|
29
|
Wang Y, Gu J, Roth JA, et al:
Pathway-based serum microRNA profiling and survival in patients
with advanced stage non-small cell lung cancer. Cancer Res.
73:4801X–4809. 2013. View Article : Google Scholar
|
|
30
|
Delfino KR and Rodriguez-Zas SL:
Transcription factor-microRNA-target gene networks associated with
ovarian cancer survival and recurrence. PLoS One. 8:e586082013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reid G, Pel ME, Kirschner MB, et al:
Restoring expression of miR-16: a novel approach to therapy for
malignant pleural mesothelioma. Ann Oncol. 24:3128–3155. 2013.
View Article : Google Scholar : PubMed/NCBI
|
